SCHEMBL20218243

SCHEMBL20218243

O=Cc1oc(CO)cc(=O)c1OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEAD4 Q15561 4/20 0.42
DAO P14920 1/20 0.42
CREB1 P16220 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
GSTP1 P09211 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
RAB9A P51151 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
IDH1 O75874 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16921607 0.87 LMNA (0.44) DAOCREB1LMNAGAAGSTP1
SCHEMBL10290054 0.87 LMNA (0.41) DAOCREB1LMNAGAAGSTP1
SCHEMBL7622844 0.82 KDM4E (0.48) TEAD4DAOCREB1LMNAGAA
SCHEMBL2115663 0.82 LMNA (0.50) CREB1LMNAGAAGSTP1MEN1
SCHEMBL22997609 0.81 LMNA (0.56) TEAD4DAOCREB1LMNAGAA
SCHEMBL31281619 0.81 THRA (0.44) TEAD4DAOCREB1LMNAGAA
SCHEMBL17402173 0.81 ABCG2 (0.39) CREB1LMNAGAAGSTP1MEN1
SCHEMBL22872659 0.80 TEAD4 (0.43) TEAD4DAOCREB1LMNAGAA
SCHEMBL11092303 0.80 CREB1 (0.47) TEAD4DAOCREB1LMNAGAA
SCHEMBL752436 0.80 LMNA (0.38) CREB1LMNAGAAGSTP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330272-B1 FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2021-02-17 EP disclosed
EP-3330272-A1 FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-06-06 EP disclosed